DGX Quest Diagnostics Загрузка... : Бычьи и медвежьи мнения аналитиков
Загрузка графика...
Лучшие сигналы
Лента
08:30
23 июл
23 июл
Management raised full-year guidance for the second time, citing strong organic growth driven by broad clinical demand, automation gains, and robust performance across channels.
Выс.
13:46
28 мая
28 мая
Vitalik Buterin expresses disappointment in the DGX spark project.
Vitalik Buterin expresses disappointment in the DGX spark project, reflecting negative sentiment but without a forward-looking trade call.
Низ.
13:00
30 апр
30 апр
Management expects the pipeline of hospital and regional lab deals to strengthen if PAMA goes into effect in January, as smaller labs will struggle to compete with scale players like LabCorp. — PAMA implementation could accelerate consolidation in the lab industry, benefiting large-scale players like LabCorp and Quest Diagnostics.
Сред.
08:30
21 апр
21 апр
Management raised full-year revenue and EPS guidance after a strong Q1 driven by broad-based organic growth, advanced diagnostics, and productivity improvements from automation and AI.
Выс.
08:30
10 фев
10 фев
Management issued guidance for 6-7% revenue growth and expanding margins, backed by strong organic volume, advanced diagnostics momentum, and consumer channel growth, despite weather headwinds.
Выс.
08:30
21 окт
21 окт
Quest raised full-year guidance on broad-based demand, organic growth acceleration, and margin expansion, signaling sustained momentum.
Выс.
Об аналитическом покрытии DGX
Buzzberg отслеживает DGX (Quest Diagnostics) в 2 источниках. Бычьих сигналов: 0, медвежьих: 0, от 4 аналитиков. Сентимент разделён поровну. Всего отслеживается 6 торговых идей. Последние спикеры: Sam Samad, Vitalik Buterin, Adam Schechter.